精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南：双相障碍的管理

2019-03-19 中华精神科杂志.2019, 52(1):5-49.

双相障碍

2018版CANMAT／ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展，包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别，并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等，对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相I型障碍(BD—I)的躁狂发作

中文标题：

2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南：双相障碍的管理

发布机构：

发布日期：

2019-03-19

简要介绍：

2018版CANMAT／ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展，包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别，并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等，对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相I型障碍(BD—I)的躁狂发作急性期、抑郁发作急性期和双相障碍维持期的一线及二线治疗推荐等级划分。 

译者： 首都医科大学附属北京安定医院 胡晨 王刚 

拓展指南：与双相障碍相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南：双相障碍的管理)] GetToolGuiderByIdResponse(projectId=1, id=e7de31c001e2680e, title=2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南：双相障碍的管理, enTitle=, guiderFrom=中华精神科杂志.2019, 52(1):5-49., authorId=null, author=, summary=2018版CANMAT／ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展，包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别，并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等，对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相I型障碍(BD—I)的躁狂发作, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Mar 19 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2018版CANMAT／ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展，包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别，并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等，对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相I型障碍(BD—I)的躁狂发作急性期、抑郁发作急性期和双相障碍维持期的一线及二线治疗推荐等级划分。 </div> <div><br> </div><div>译者： 首都医科大学附属北京安定医院 胡晨 王刚 </div><div><br></div> 拓展指南：<strong>与<font color=red>双相障碍</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=ca7651c001569328" title="2018 CANMAT/ISBD指南：双相障碍患者的管理" target=_blank>2018 CANMAT/ISBD指南：双相障碍患者的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5e57c1c00151eae5" title="2017 WFSBP双相障碍生物学治疗指南：双相情感障碍混合状态的急性和长期治疗" target=_blank>2017 WFSBP双相障碍生物学治疗指南：双相情感障碍混合状态的急性和长期治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=636f71c001a21100" title="2017 应用锂盐治疗双相障碍的指南建议" target=_blank>2017 应用锂盐治疗双相障碍的指南建议</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=cd7111c00136202e" title="2017 CINP指南：成人双相障碍的治疗" target=_blank>2017 CINP指南：成人双相障碍的治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a66f71c001112660" title="2014 NICE临床指南：在初级和二级医疗中成人，儿童以及青年人双相障碍的评估和管理（CG185）" target=_blank>2014 NICE临床指南：在初级和二级医疗中成人，儿童以及青年人双相障碍的评估和管理（CG185）</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E5%8F%8C%E7%9B%B8%E9%9A%9C%E7%A2%8D" target=_blank>有关双相障碍更多指南</a></ul>, tagList=[TagDto(tagId=8327, tagName=双相障碍)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8046, appHits=405, showAppHits=0, pcHits=4279, showPcHits=4771, likes=83, shares=23, comments=9, approvalStatus=1, publishedTime=Fri Apr 19 13:30:37 CST 2019, publishedTimeString=2019-03-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 19 13:30:37 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 09:43:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南：双相障碍的管理)])
2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南：双相障碍的管理
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=968270, encodeId=f80b9682e0d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/723d0cec261d4fb6afa3a3b941969dc0/0a0bad5bb1404d8ca8d6d03177f13410.jpg, createdBy=f5735507122, createdName=花间一壶酒, createdTime=Mon May 24 22:43:03 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947169, encodeId=ffc194e16998, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60c5419111, createdName=ms2000000188986137, createdTime=Wed Mar 10 16:52:03 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946226, encodeId=673c946226b9, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:41 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946225, encodeId=729294622534, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:25 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905210, encodeId=09e79052103b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19335441694, createdName=ms2000001252028403, createdTime=Sat Dec 05 16:45:09 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2021-05-24 花间一壶酒

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=968270, encodeId=f80b9682e0d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/723d0cec261d4fb6afa3a3b941969dc0/0a0bad5bb1404d8ca8d6d03177f13410.jpg, createdBy=f5735507122, createdName=花间一壶酒, createdTime=Mon May 24 22:43:03 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947169, encodeId=ffc194e16998, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60c5419111, createdName=ms2000000188986137, createdTime=Wed Mar 10 16:52:03 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946226, encodeId=673c946226b9, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:41 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946225, encodeId=729294622534, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:25 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905210, encodeId=09e79052103b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19335441694, createdName=ms2000001252028403, createdTime=Sat Dec 05 16:45:09 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2021-03-10 ms2000000188986137

    指南下载

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=968270, encodeId=f80b9682e0d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/723d0cec261d4fb6afa3a3b941969dc0/0a0bad5bb1404d8ca8d6d03177f13410.jpg, createdBy=f5735507122, createdName=花间一壶酒, createdTime=Mon May 24 22:43:03 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947169, encodeId=ffc194e16998, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60c5419111, createdName=ms2000000188986137, createdTime=Wed Mar 10 16:52:03 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946226, encodeId=673c946226b9, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:41 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946225, encodeId=729294622534, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:25 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905210, encodeId=09e79052103b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19335441694, createdName=ms2000001252028403, createdTime=Sat Dec 05 16:45:09 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2021-03-07 133pqTQ4253

    指南下载

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=968270, encodeId=f80b9682e0d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/723d0cec261d4fb6afa3a3b941969dc0/0a0bad5bb1404d8ca8d6d03177f13410.jpg, createdBy=f5735507122, createdName=花间一壶酒, createdTime=Mon May 24 22:43:03 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947169, encodeId=ffc194e16998, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60c5419111, createdName=ms2000000188986137, createdTime=Wed Mar 10 16:52:03 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946226, encodeId=673c946226b9, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:41 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946225, encodeId=729294622534, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:25 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905210, encodeId=09e79052103b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19335441694, createdName=ms2000001252028403, createdTime=Sat Dec 05 16:45:09 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2021-03-07 133pqTQ4253

    这个好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=968270, encodeId=f80b9682e0d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/723d0cec261d4fb6afa3a3b941969dc0/0a0bad5bb1404d8ca8d6d03177f13410.jpg, createdBy=f5735507122, createdName=花间一壶酒, createdTime=Mon May 24 22:43:03 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947169, encodeId=ffc194e16998, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60c5419111, createdName=ms2000000188986137, createdTime=Wed Mar 10 16:52:03 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946226, encodeId=673c946226b9, content=指南下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:41 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946225, encodeId=729294622534, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1d82152635, createdName=133pqTQ4253, createdTime=Sun Mar 07 19:26:25 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905210, encodeId=09e79052103b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19335441694, createdName=ms2000001252028403, createdTime=Sat Dec 05 16:45:09 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2020-12-05 ms2000001252028403

    学习了

    0

相关指南

2018 CANMAT/ISBD指南：双相障碍患者的管理

加拿大情绪和焦虑治疗网络(CANMAT,Canadian Network for Mood and Anxiety Treatments) · 2018-03-14

2017 WFSBP双相障碍生物学治疗指南：双相情感障碍混合状态的急性和长期治疗

世界生物精神病学会联合会(WFSBP,World Federation of Societies of Biological Psychiatry) · 2017-11-03

2017 CINP指南：成人双相障碍的治疗

国际神经精神药理学学会(CINP,International College of Neuropsychopharmacology) · 2016-12-10

2014 NICE临床指南：在初级和二级医疗中成人，儿童以及青年人双相障碍的评估和管理（CG185）

暂未更新 · 2014-09-20